CX3CR1 and type 1 diabetes mellitus: The fractalkine receptor CX3CR1, previously associated with recruitment of pro-atherosclerotic cells and their retention in the vessel wall [15], was co-expressed on the majority of CD16pos monocyte subtypes and less frequent on CD14hiCD16neg monocytes, with no significant differences between H and T1D (Fig. 1B).